130 related articles for article (PubMed ID: 19965315)
1. [Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].
Yerebakan C; Uğurlucan M; Kaminski A; Westphal B; Liebold A; Steinhoff G
Anadolu Kardiyol Derg; 2009 Dec; 9(6):457-64. PubMed ID: 19965315
[TBL] [Abstract][Full Text] [Related]
2. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
[TBL] [Abstract][Full Text] [Related]
3. [Autologous stem cell therapy with surgical myocardial revascularization].
Durdu S; Cubukçuoğlu Deniz G; Akar AR
Anadolu Kardiyol Derg; 2009 Dec; 9(6):465-6. PubMed ID: 19965316
[No Abstract] [Full Text] [Related]
4. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
[TBL] [Abstract][Full Text] [Related]
5. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
[TBL] [Abstract][Full Text] [Related]
6. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
[TBL] [Abstract][Full Text] [Related]
7. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
8. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
[TBL] [Abstract][Full Text] [Related]
9. Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction.
Laguna G; DI Stefano S; Maroto L; Fulquet E; Echevarría JR; Revilla A; Urueña N; Sevilla T; Arnold R; Ramos B; Gutiérrez H; Serrador A; San Román JA
J Cardiovasc Surg (Torino); 2018 Apr; 59(2):259-267. PubMed ID: 29582623
[TBL] [Abstract][Full Text] [Related]
10. The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133
Noiseux N; Mansour S; Weisel R; Stevens LM; Der Sarkissian S; Tsang K; Crean AM; Larose E; Li SH; Wintersperger B; Vu MQ; Prieto I; Li RK; Roy DC; Yau TM
J Thorac Cardiovasc Surg; 2016 Dec; 152(6):1582-1588.e2. PubMed ID: 27665225
[TBL] [Abstract][Full Text] [Related]
11. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
[TBL] [Abstract][Full Text] [Related]
12. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.
Ahmadi H; Baharvand H; Ashtiani SK; Soleimani M; Sadeghian H; Ardekani JM; Mehrjerdi NZ; Kouhkan A; Namiri M; Madani-Civi M; Fattahi F; Shahverdi A; Dizaji AV
Curr Neurovasc Res; 2007 Aug; 4(3):153-60. PubMed ID: 17691968
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of isolated transmyocardial laser revascularization in combination with the intramyocardial autologous bone marrow stem cells injection.
Bockeria OL; Petrosyan AD; Shvartz VA; Donakanyan SA; Biniashvili MB; Sokolskaya MA; Ispiryan AY; Bockeria LA
Lasers Med Sci; 2020 Jul; 35(5):1111-1117. PubMed ID: 31797237
[TBL] [Abstract][Full Text] [Related]
14. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial.
Hendrikx M; Hensen K; Clijsters C; Jongen H; Koninckx R; Bijnens E; Ingels M; Jacobs A; Geukens R; Dendale P; Vijgen J; Dilling D; Steels P; Mees U; Rummens JL
Circulation; 2006 Jul; 114(1 Suppl):I101-7. PubMed ID: 16820557
[TBL] [Abstract][Full Text] [Related]
15. A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction.
Lu M; Liu S; Zheng Z; Yin G; Song L; Chen H; Chen X; Chen Q; Jiang S; Tian L; He Z; Hu S; Zhao S
Int J Cardiol; 2013 Oct; 168(3):2221-7. PubMed ID: 23478196
[TBL] [Abstract][Full Text] [Related]
16. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
[TBL] [Abstract][Full Text] [Related]
17. The combined use of transmyocardial laser revascularisation and intramyocardial injection of bone-marrow derived stem cells in patients with end-stage coronary artery disease: one year follow-up.
Konstanty-Kalandyk J; Piątek J; Miszalski-Jamka T; Rudziński P; Walter Z; Bartuś K; Urbańczyk-Zawadzka M; Sadowski J
Kardiol Pol; 2013; 71(5):485-92. PubMed ID: 23788089
[TBL] [Abstract][Full Text] [Related]
18. Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction.
Soetisna TW; Sukmawan R; Setianto B; Mansyur M; Murni TW; Listiyaningsih E; Santoso A
J Card Surg; 2020 Apr; 35(4):740-746. PubMed ID: 32048356
[TBL] [Abstract][Full Text] [Related]
19. Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial.
Garzillo CL; Hueb W; Gersh BJ; Lima EG; Rezende PC; Hueb AC; Vieira RD; Favarato D; Pereira AC; Soares PR; Serrano CV; Ramires JA; Kalil Filho R
Eur Heart J; 2013 Nov; 34(43):3370-7. PubMed ID: 23828828
[TBL] [Abstract][Full Text] [Related]
20. Safety of intramyocardial stem cell therapy for the ischemic myocardium: results of the Rostock trial after 5-year follow-up.
Yerebakan C; Kaminski A; Liebold A; Steinhoff G
Cell Transplant; 2007; 16(9):935-40. PubMed ID: 18293892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
